Oramed Pharmaceuticals (ORMP) Rating Lowered to Sell at ValuEngine

Retrieved on: 2018-02-21 20:11:15

Tags for this article:

Pharmaceuticals policy

Pharmaceutical industry in China

NASDAQ Biotechnology Index

Science and technology in the People's Republic of China

Pharmaceutical industry of China

Oramed Pharmaceuticals

Click the tags to see associated articles and topics

Oramed Pharmaceuticals (ORMP) Rating Lowered to Sell at ValuEngine. View article details on hiswai:

Excerpt

<div>Millennium Management LLC purchased a new position in Oramed Pharmaceuticals in the 4th quarter worth approximately $143,000. <b>Renaissance</b> <b>Technologies</b> LLC boosted its holdings in Oramed Pharmaceuticals by 12.7% in the 4th quarter. <b>Renaissance Technologies</b> LLC now owns 93,500 shares ...</div>

Article found on:

View Original Article